The insurance industry is pushing a seductive narrative these days: skip the medical exam, get approved faster, enjoy the convenience of modern underwriting. No-exam life insurance products are multiplying, and marketing departments are working overtime to position them as a win for busy consumers who don't have time for needles and questionnaires.
This trend is being sold as inevitable. It deserves more skepticism than it is getting.
Don't misunderstand. The friction of traditional underwriting is real, and the desire to streamline it is understandable. Medical exams are inconvenient. They require scheduling, time off work, uncomfortable moments in a clinic. For people managing packed lives, the appeal of avoiding all that is genuine. Insurance companies know this, and they're leveraging it brilliantly.
But we should pause before celebrating this shift as pure progress.
The core question nobody wants to ask out loud is this: if insurers can approve policies without examining your health, what does that mean for how they're pricing risk? The answer matters enormously for consumers, yet it's buried under layers of marketing about convenience and accessibility.
When an insurer skips medical underwriting, they don't eliminate risk assessment. They redistribute it. Some of that risk gets priced into higher premiums for everyone buying no-exam products. Some of it gets managed through tighter underwriting on other dimensions. Some of it simply shifts to the company's loss reserves, which eventually affects profitability and, by extension, the products insurers can afford to offer.
What we're witnessing isn't a neutral technological upgrade. It's a business model shift that benefits certain customers while potentially disadvantaging others. Someone in excellent health who buys a no-exam policy is effectively subsidizing the risk pool that includes less healthy applicants. That might sound like a virtuous outcome. But consider the flipside: people who are willing to undergo traditional medical exams to get better rates are selecting themselves into a separate category. The pool that remains includes a higher proportion of people who prefer avoiding scrutiny.
This is the insurance industry's version of a classic economic problem. When you make one option cheaper and easier, you change who chooses it. That changes the composition of the risk pool. That changes the pricing dynamics for everyone.
The industry's marketing suggests this is simply about giving people choices. Technically, that's true. But choices matter most when consumers understand the tradeoffs. How many people buying a no-exam policy understand that they might be paying a premium for that convenience? How many realize they're potentially in a riskier pool with higher average costs? My guess is not many.
We've seen this movie before in other insurance segments. When technology made it easier to collect certain data points, insurers built pricing models around them. Dash cams, credit scores, telematics data in cars. Each innovation arrived with promises of fairness and accuracy. Some delivered. Others created new blind spots or exacerbated existing inequities. The track record is mixed at best.
The honest version of the no-exam insurance pitch would sound something like this: "We can approve you without a medical exam, but we're pricing that convenience and that risk profile accordingly." That's not as catchy. It doesn't get the same media coverage. But it's the version that respects consumer intelligence.
For people considering no-exam products, the responsible approach is the same as with any insurance decision: understand what you're buying and why it costs what it does. Don't assume convenience is free. Someone is paying for it. Often, that someone is you.